Stay Informed

Memory Enhancement Center

↑ Grab this Headline Animator

Enter your email address:

Delivered by FeedBurner

Medical Links

Links

Search


 
Joel S. Ross, MD, FACP, AGSF, CMD President and Founder of Memory Enhancement Center of America
 

Joel S. Ross, MD

MD FACP AGSF CMD CPI
President and Founder
 
Memory Enhancement Center
of America, Inc.
4 Industrial Way West, 2nd Floor
Eatontown, New Jersey 07724
732.571.1535
 

Clinical Research Study

« Previous Entries

Will Dimebon be the next FDA approved Drug for AD?

Monday, January 11th, 2010

I have been very actively researching Dimebon in clinical research studies under strict FDA and industry guidelines, and saw the below article and felt my readers would be most interested in learning more about an “outsider” looking in at the potential for this drug if FDA approved for Alzheimer’s Disease.
For the Treatment of Alzheimer’s Disease, [...]

Memory Enhancement Center(s) now open in Toms River NJ and Brooklyln NY

Thursday, December 24th, 2009

The Memory Enhancement Centers of America are very proud to have added the Toms River NJ site headed by Dr. Sanjiv Sharma, MD (board certified fellowship trained geriatrician) and the Memory Enhancement Center of Brooklyn, headed by Dr. Jeffrey Ben-Zvi, MD (board certified in geriatric medicine).
These two centers of excellence will now provide even more [...]

Iberica USA opens its new State of Art Phase I/IIA Facility

Thursday, January 17th, 2008

Iberica USA has announced that its new 28 bed inpatient facility is officially open effective January 18, 2008. Iberica’s Clinical Research Center (ICRC) will bring a new level of high quality phase I/IIA research to the pharmaceutical world.
It “home like” environment, 20 single rooms and 4 double bedded rooms, staffed with the most caring and [...]

 
icon for podpress  Dr. Ross radio interview - on WOBM-AM - Bob and Marianne [12:07m]: Play Now | Play in Popup | Download

New Approaches to Alzheimer’s Disease Treatments

Thursday, January 17th, 2008

   Want to know the newest ways to treat AD? 
Elan progresses two of its Alzheimer’s compounds with partners
Elan and Transition Therapeutics have started a Phase II trial of the potential Alzheimer’s disease compound they are jointly developing, ELND005 (formerly AZD-103).
ELND005 is an orally administered product that was shown in animal models to act by preventing and [...]

Americas Seniors: The Overmedicated Society?

Friday, January 11th, 2008

AMERICAS SENIORS:
THE OVERMEDICATED SOCIETY?
 
The value of a geriatric consultation
 
By Joel S. Ross, MD, FACP, AGSF, CMD
Geriatric Specialist
I saw an elderly patient recently who came for a geriatric evaluation. She had recalled how 15 years earlier I had cared for her husband, and said “you were so caring for my husband and I hope you can [...]

« Previous Entries